No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract: Intrapartum azithromycin does not reduce neonatal sepsis or mortality

byZain Cheema

April 21, 2023

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Intrapartum azithromycin does not reduce neonatal sepsis or mortality

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

RelatedReports

Behavioral dysregulation in infancy predicts later child mental health

Imaging and Intervention

Epidural analgesia in labour is not associated with adverse neonatal health outcomes

July 23, 2026

Obstetric scoring systems overestimate cases of severe sepsis

Emergency

Use of procalcitonin in neonatal late-onset sepsis may reduce the duration of antibiotic therapy without increase in mortality

May 28, 2026

All Specialties

Maternal prothrombin time may be an effective marker for neonatal sepsis risk stratification

March 25, 2026

Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity

Weekly Rewinds

2 Minute Medicine Rewind March 23, 2026

March 23, 2026

Study explores effects of daily iron supplementation in 2- to 5-year-olds

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact

Sodium bicarbonate does not prevent declining kidney function in kidney transplant recipients

Nivolumab may be effective in platinum-resistant ovarian cancer

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Intrapartum azithromycin does not reduce neonatal sepsis or mortality

Epidural analgesia in labour is not associated with adverse neonatal health outcomes

Use of procalcitonin in neonatal late-onset sepsis may reduce the duration of antibiotic therapy without increase in mortality

Maternal prothrombin time may be an effective marker for neonatal sepsis risk stratification

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

RelatedReports

Epidural analgesia in labour is not associated with adverse neonatal health outcomes

Use of procalcitonin in neonatal late-onset sepsis may reduce the duration of antibiotic therapy without increase in mortality

Maternal prothrombin time may be an effective marker for neonatal sepsis risk stratification

2 Minute Medicine Rewind March 23, 2026

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

Sodium bicarbonate does not prevent declining kidney function in kidney transplant recipients

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits

#VisualAbstract: Intrapartum azithromycin does not reduce neonatal sepsis or mortality

RELATED REPORTS

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

RelatedReports

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits